THE PRIMER
SCIENCE MADE SIMPLE
Stay Updated! Subscribe to The Primer
Share
Unintended Consequences of Ozempic’s Viral Popularity
Ozempic’s viral transition from diabetes management to a trending weight loss solution raises questions about the broader impact of…
New Gene Therapy Drug Explained
In March 2023, Novartis’ (Basel, Switzerland), shared its latest data concerning Zolgensma. The findings reveal sustained durability up to 7.5 years post-dosing, with a 100% achievement of all assessed milestones in children treated before the onset of spinal muscular...
Gluten: Protein of Doom
Imagine the tantalizing scent of freshly baked bread. Now, think about even a single scrumptious slice wreaking havoc on you: stomach pain, bloating, and other digestive consequences. Welcome to Planet Celiac— home to the millions of Americans diagnosed with celiac...
Ticked Off: the Science Behind Lyme Disease
Alleluia! Spring! It means the promise of more time in the fresh air – gardening, camping, or just enjoying the sunshine. Unfortunately, time outdoors increases the risk of contracting Lyme disease. As you may know, this illness comes courtesy of our favorite...
From Drug Discovery to Approval: Phase IV
We previously focused on the final stage of clinical testing, Phase III trials, where drug developers assess the safety and efficacy of their drug in large patient groups. At the end of Phase III, drug developers face the moment of truth: does the study data support...
From Drug Discovery to Approval: Phase III
Our recent article explored the riskiest part of the human clinical trials pathway: Phase II. About 70% of drugs that enter Phase II never make it out. Most often, it’s because they fail to demonstrate effectiveness. Even making it to Phase III is no guarantee of...
From Drug Discovery to Approval: Phase I/II
Every drug in clinical use today, from the latest CAR-T treatment to older cholesterol-lowering statins, share one thing in common: they have all successfully navigated the rigorous clinical trials process. This is no small feat, as only ~10% of the drugs that enter...
Blueprint of The Century: DNA
Please enjoy this excerpt from our book, Biotech Primer One: The Science Driving Biopharma Explained. Written for the non-scientist, this book aims to enhance your comprehension of the foundational biology needed to understand today’s advanced therapies, such as gene...
Pharmaceutical Commercialization: Bringing Cures to Patients
Pharmaceutical commercialization refers to bringing a new drug or therapy to the market and making it available to patients. It is a critical stage in the pharmaceutical industry, involving various activities such as regulatory approvals, distribution, marketing, and...
Drug Commercialization Process: From Research to Market
The drug commercialization process is critical in bringing new pharmaceuticals to market. It involves a complex series of steps, from initial research and development to clinical trials, regulatory approval, and commercialization. For pharmaceutical companies, the...
Biotech Primer is your go-to source for interactive training across the biotechnology, pharmaceutical, molecular diagnostics, and medical device sectors. Explore a range of in-depth biotech courses designed to deepen your understanding of key principles and applications in the field.